Meridian Investment Counsel’s Merck MRK Stock Holding History

Meridian Investment Counsel’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$504K	Buy	3,923 +130	+3%	+$15.2K	0.11%	162
2026 Q1	$456K	Sell	3,793 -689	-15%	-$79.5K	0.11%	166
2025 Q4	$472K	Sell	4,482 -295	-6%	-$27.7K	0.11%	160
2025 Q3	$401K	Hold	4,777	–	–	0.1%	168
2025 Q2	$378K	Sell	4,777 -2	-0%	-$159	0.1%	160
2025 Q1	$429K	Hold	4,779	–	–	0.13%	151
2024 Q4	$475K	Hold	4,779	–	–	0.14%	136
2024 Q3	$543K	Hold	4,779	–	–	0.16%	131
2024 Q2	$592K	Buy	4,779 +50	+1%	+$6.44K	0.19%	123
2024 Q1	$624K	Sell	4,729 -68	-1%	-$8.38K	0.21%	113
2023 Q4	$523K	Hold	4,797	–	–	0.18%	126
2023 Q3	$494K	Hold	4,797	–	–	0.19%	123
2023 Q2	$554K	Buy	4,797 +51	+1%	+$5.79K	0.2%	117
2023 Q1	$505K	Hold	4,746	–	–	0.19%	118
2022 Q4	$527K	Sell	4,746 -450	-9%	-$46K	0.21%	110
2022 Q3	$447K	Buy	5,196 +246	+5%	+$22K	0.2%	120
2022 Q2	$451K	Hold	4,950	–	–	0.19%	123
2022 Q1	$406K	Sell	4,950 -795	-14%	-$62.7K	0.14%	149
2021 Q4	$440K	Buy	5,745 +120	+2%	+$9.56K	0.15%	144
2021 Q3	$422K	Hold	5,625	–	–	0.15%	136
2021 Q2	$437K	Sell	5,625 -270	-5%	-$20.1K	0.15%	137
2021 Q1	$434K	Hold	5,895	–	–	0.17%	129
2020 Q4	$460K	Hold	5,895	–	–	0.19%	115
2020 Q3	$467K	Buy	5,895 +943	+19%	+$73.9K	0.23%	101
2020 Q2	$365K	Hold	4,952	–	–	0.19%	114
2020 Q1	$364K	Sell	4,952 -398	-7%	-$31.3K	0.24%	98
2019 Q4	$464K	Buy	5,350 +2	+0%	+$164	0.23%	107
2019 Q3	$430K	Buy	5,348 +3	+0.1%	+$240	0.23%	107
2019 Q2	$428K	Buy	5,345 +33	+0.6%	+$2.53K	0.24%	106
2019 Q1	$422K	Buy	5,312 +3	+0.1%	+$224	0.25%	105
2018 Q4	$387K	Buy	5,309 +2	+0%	+$141	0.25%	101
2018 Q3	$359K	Buy	5,307 +3	+0.1%	+$191	0.2%	118
2018 Q2	$307K	Buy	5,304 +3	+0.1%	+$169	0.17%	131
2018 Q1	$275K	Sell	5,301 -7	-0.1%	-$378	0.16%	135
2017 Q4	$285K	Buy	5,308 +3	+0.1%	+$166	0.15%	143
2017 Q3	$324K	Buy	5,305 +3	+0.1%	+$182	0.19%	129
2017 Q2	$324K	Buy	5,302 +2	+0%	+$122	0.19%	130
2017 Q1	$321K	Buy	5,300 +3	+0.1%	+$182	0.2%	133
2016 Q4	$298K	Sell	5,297 -1,045	-16%	-$61.2K	0.2%	131
2016 Q3	$378K	Buy	6,342 +3	+0%	+$175	0.25%	109
2016 Q2	$348K	Buy	6,339 +3	+0%	+$160	0.24%	115
2016 Q1	$320K	Buy	6,336 +529	+9%	+$25.9K	0.22%	117
2015 Q4	$293K	Buy	5,807 +535	+10%	+$27K	0.22%	115
2015 Q3	$248K	Sell	5,272 -1,572	-23%	-$83.5K	0.2%	121
2015 Q2	$372K	Hold	6,844	–	–	0.27%	103
2015 Q1	$375K	Hold	6,844	–	–	0.26%	103
2014 Q4	$371K	Hold	6,844	–	–	0.27%	100
2014 Q3	$387K	Buy	6,844 +1,048	+18%	+$58.8K	0.29%	99
2014 Q2	$320K	Buy	5,796 +1,594	+38%	+$87K	0.25%	109
2014 Q1	$228K	Sell	4,202 -27	-0.6%	-$1.4K	0.19%	128
2013 Q4	$202K	Buy	+4,229	New	+$193K	0.17%	132

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Meridian Investment Counsel's MRK Position: Q2 2026 in Review

Meridian Investment Counsel increased its Merck (MRK) stake by 3.4% in Q2 2026, buying an estimated $15.2K and bringing the position to 3,923 shares worth $504K. The position accounts for 0.11% of the portfolio, ranked #162.

Meridian Investment Counsel first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. The position peaked at $624K in Q1 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Meridian Investment Counsel held 3,923 shares of Merck worth $504K as of Q2 2026.
Meridian Investment Counsel bought 130 Merck shares in Q2 2026, an estimated $15.2K.
Merck made up 0.11% of Meridian Investment Counsel's portfolio in Q2 2026, its #162 holding.
Meridian Investment Counsel first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
Meridian Investment Counsel's Merck position peaked at $624K in Q1 2024.
1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.